Continuous response despite reduced dose of trametinib as single agent in an adolescent with a relapsed disseminated pediatric low-grade glioma KIAA1549-BRAF fusion positive: a case report and review of the literature

  1. Castellano-Damaso, S.
  2. Vazquez-Gomez, F.
  3. Moreno-Carrasco, J.L.
  4. Arce, B.
  5. Borrego, P.
  6. Lassaletta, A.
Zeitschrift:
Frontiers in Oncology

ISSN: 2234-943X

Datum der Publikation: 2024

Ausgabe: 14

Art: Artikel

DOI: 10.3389/FONC.2024.1381354 GOOGLE SCHOLAR lock_openOpen Access editor